DK2069528T3 - Fremgangsmåde til diagnosticering af atherosklerotiske plaques ved måling af CD36 - Google Patents

Fremgangsmåde til diagnosticering af atherosklerotiske plaques ved måling af CD36

Info

Publication number
DK2069528T3
DK2069528T3 DK08700920.5T DK08700920T DK2069528T3 DK 2069528 T3 DK2069528 T3 DK 2069528T3 DK 08700920 T DK08700920 T DK 08700920T DK 2069528 T3 DK2069528 T3 DK 2069528T3
Authority
DK
Denmark
Prior art keywords
measuring
atherosclerotic plaques
diagnosing atherosclerotic
diagnosing
plaques
Prior art date
Application number
DK08700920.5T
Other languages
English (en)
Inventor
Bente Halvorsen
Paal Aukrust
Mona Skjelland
Aase Handberg
Original Assignee
Region Nordjylland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Region Nordjylland filed Critical Region Nordjylland
Application granted granted Critical
Publication of DK2069528T3 publication Critical patent/DK2069528T3/da

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/106Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70596Molecules with a "CD"-designation not provided for elsewhere in G01N2333/705
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/32Cardiovascular disorders
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/32Cardiovascular disorders
    • G01N2800/323Arteriosclerosis, Stenosis
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/50Determining the risk of developing a disease
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/52Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/56Staging of a disease; Further complications associated with the disease

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DK08700920.5T 2007-02-05 2008-02-04 Fremgangsmåde til diagnosticering af atherosklerotiske plaques ved måling af CD36 DK2069528T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200700192 2007-02-05
PCT/DK2008/000049 WO2008095492A2 (en) 2007-02-05 2008-02-04 A method for diagnosing atherosclerotic plaques by measurement of cd36

Publications (1)

Publication Number Publication Date
DK2069528T3 true DK2069528T3 (da) 2013-05-21

Family

ID=39579960

Family Applications (1)

Application Number Title Priority Date Filing Date
DK08700920.5T DK2069528T3 (da) 2007-02-05 2008-02-04 Fremgangsmåde til diagnosticering af atherosklerotiske plaques ved måling af CD36

Country Status (8)

Country Link
US (4) US20100105088A1 (da)
EP (1) EP2069528B1 (da)
CN (1) CN101627135B (da)
AU (1) AU2008213472A1 (da)
CA (1) CA2712834A1 (da)
DK (1) DK2069528T3 (da)
ES (1) ES2415375T3 (da)
WO (1) WO2008095492A2 (da)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2069528T3 (da) * 2007-02-05 2013-05-21 Region Nordjylland Fremgangsmåde til diagnosticering af atherosklerotiske plaques ved måling af CD36
WO2011063470A1 (en) 2009-11-27 2011-06-03 Baker Idi Heart And Diabetes Institute Holdings Limited Lipid biomarkers for stable and unstable heart disease
WO2012058269A2 (en) 2010-10-29 2012-05-03 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Methods of treating cancer and other diseases
WO2012149465A2 (en) * 2011-04-27 2012-11-01 Isis Pharmaceuticals, Inc. Modulation of cd36 expression
US10779855B2 (en) 2011-08-05 2020-09-22 Route 92 Medical, Inc. Methods and systems for treatment of acute ischemic stroke
EP2739217B1 (en) 2011-08-05 2022-07-20 Route 92 Medical, Inc. Systems for treatment of acute ischemic stroke
EP2839292A4 (en) * 2012-04-19 2015-08-26 Univ California COMPOSITIONS AND METHODS FOR DETECTING INSTABLIC ARTERIOSCLEOTIC PLAQUE
US9265512B2 (en) 2013-12-23 2016-02-23 Silk Road Medical, Inc. Transcarotid neurovascular catheter
US11065019B1 (en) 2015-02-04 2021-07-20 Route 92 Medical, Inc. Aspiration catheter systems and methods of use
CA2983072A1 (en) 2015-02-04 2016-08-11 Route 92 Medical, Inc. Rapid aspiration thrombectomy system and method
WO2017019563A1 (en) 2015-07-24 2017-02-02 Route 92 Medical, Inc. Anchoring delivery system and methods
US10716915B2 (en) 2015-11-23 2020-07-21 Mivi Neuroscience, Inc. Catheter systems for applying effective suction in remote vessels and thrombectomy procedures facilitated by catheter systems
JP7012655B2 (ja) 2016-02-24 2022-01-28 インセプト、リミテッド、ライアビリティ、カンパニー 可撓性の強化された神経血管カテーテル
EP3565511B1 (en) 2017-01-06 2023-10-18 Incept, LLC Thromboresistant coatings for aneurysm treatment devices
EP4134120A1 (en) 2017-01-10 2023-02-15 Route 92 Medical, Inc. Aspiration catheter systems
US10864350B2 (en) 2017-01-20 2020-12-15 Route 92 Medical, Inc. Single operator intracranial medical device delivery systems and methods of use
US20200131576A1 (en) * 2017-04-25 2020-04-30 The Brigham And Women's Hospital, Inc. IL-8, IL-6, IL-1 Beta and TET2 and DNMT3A in Atherosclerosis
EP3787523A4 (en) 2018-05-01 2022-02-23 Incept, LLC DEVICES AND METHODS FOR REMOVAL OF OBSTRUCTIVE MATERIAL FROM AN INTRAVASCULAR SITE
US11395665B2 (en) 2018-05-01 2022-07-26 Incept, Llc Devices and methods for removing obstructive material, from an intravascular site
CN115999019B (zh) 2018-05-17 2025-05-27 92号医疗公司 抽吸导管系统和使用方法
US11471582B2 (en) 2018-07-06 2022-10-18 Incept, Llc Vacuum transfer tool for extendable catheter
WO2020010310A1 (en) 2018-07-06 2020-01-09 Imperative Care, Inc. Sealed neurovascular extendable catheter
US11766539B2 (en) 2019-03-29 2023-09-26 Incept, Llc Enhanced flexibility neurovascular catheter
WO2021076642A1 (en) 2019-10-15 2021-04-22 Imperative Care, Inc. Systems and methods for multivariate stroke detection
EP4076611A4 (en) 2019-12-18 2023-11-15 Imperative Care, Inc. Methods and systems for treating venous thromboembolic disease
US11439799B2 (en) 2019-12-18 2022-09-13 Imperative Care, Inc. Split dilator aspiration system
US11638637B2 (en) 2019-12-18 2023-05-02 Imperative Care, Inc. Method of removing embolic material with thrombus engagement tool
CN118925025A (zh) 2020-03-10 2024-11-12 因普瑞缇夫护理公司 增强的柔韧性的神经血管导管
US11207497B1 (en) 2020-08-11 2021-12-28 Imperative Care, Inc. Catheter with enhanced tensile strength
US12582802B2 (en) 2020-10-09 2026-03-24 Route 92 Medical, Inc. Aspiration catheter systems and methods of use
US12558175B2 (en) 2021-08-12 2026-02-24 Imperative Care, Inc. Multi catheter method of performing a robotic neurovascular procedure
CN114230632B (zh) * 2021-09-18 2023-01-24 华南农业大学 一种丙烯酰胺衍生物模拟表位肽及应用
USD1077996S1 (en) 2021-10-18 2025-06-03 Imperative Care, Inc. Inline fluid filter

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9306053D0 (en) * 1993-03-24 1993-05-12 Nycomed Pharma As Method and assay
EP2305235A1 (en) * 1997-04-02 2011-04-06 The Brigham And Women's Hospital, Inc. Means of ascertaining an individual's risk profile for atherosclerotic disease
US20030219821A1 (en) * 1998-02-13 2003-11-27 Fisher Paul B. Methods for identifying oncogenes and tumor-associated proteins
JP2000180447A (ja) * 1998-12-11 2000-06-30 Dainippon Pharmaceut Co Ltd 急性心筋梗塞の判定方法及び判定用試薬
JP2001056338A (ja) * 1999-08-19 2001-02-27 Tokyoto Igaku Kenkyu Kiko 経皮的冠動脈形成術後の冠動脈再狭窄の可能性を検出する方法
US6812023B1 (en) * 2000-04-27 2004-11-02 Anosys, Inc. Methods of producing membrane vesicles
AU2003259340A1 (en) * 2002-08-23 2004-03-11 Gestion Univalor Societe En Commandite Growth hormone-releasing peptides in the treatment of prevention of atherosclerosis and hypercholesterolemia
US20040076621A1 (en) * 2002-10-16 2004-04-22 Isis Pharmaceuticals Inc. Antisense modulation of CD36 expression
EP1431399A1 (en) * 2002-12-20 2004-06-23 Clinigenetics Methods and composition for identifying therapeutic agents of atherosclerotic plaque lesions
US20050032117A1 (en) * 2003-02-14 2005-02-10 Seikagaku Corporation Method for assessment of cystic lung fibrosis
WO2005117859A2 (en) * 2004-05-11 2005-12-15 Joslin Diabetes Center, Inc. Methods of diagnosing cardiovascular disease
BRPI0511489B8 (pt) * 2004-05-26 2016-12-20 Aase Handberg método de avaliação do risco relativo de desenvolver aterosclerose em pacientes
DK2069528T3 (da) * 2007-02-05 2013-05-21 Region Nordjylland Fremgangsmåde til diagnosticering af atherosklerotiske plaques ved måling af CD36

Also Published As

Publication number Publication date
US20140371089A1 (en) 2014-12-18
US20100105088A1 (en) 2010-04-29
WO2008095492A2 (en) 2008-08-14
EP2069528A2 (en) 2009-06-17
US20160377632A1 (en) 2016-12-29
WO2008095492A3 (en) 2008-10-02
AU2008213472A1 (en) 2008-08-14
EP2069528B1 (en) 2013-03-27
CN101627135A (zh) 2010-01-13
ES2415375T3 (es) 2013-07-25
CA2712834A1 (en) 2008-08-14
CN101627135B (zh) 2013-04-10
US20110212471A1 (en) 2011-09-01

Similar Documents

Publication Publication Date Title
DK2157903T3 (da) Fremgangsmåde til iagttagelsesmåling
EP2215261A4 (en) METHOD FOR DIAGNOSING TUMOR DISEASES
IL211217A0 (en) Methods for evaluating chromatography column performance
DK2050765T3 (da) Fremgangsmåder til anvendelse ved til mennesker tilpassede antistoffer
EP2296813C0 (en) INTEGRATED ANALYTIC DEVICES
EP2190629A4 (en) REST MOMENT ANALYSIS DEVICE
EP2009611A4 (en) ROAD SHARING LINE DETECTOR
NO20080454L (no) Anordning ved turbinmontasje
EP2116827A4 (en) SPECTROSCOPE
DK2313364T3 (da) Fremgangsmåder til detektering af symmetrisk demethylarginin
FI20080493A0 (fi) Menetelmä hiilinielun mittaamiseksi
DK3106875T3 (da) Fremgangsmåde til detektering af cancer
PL2254850T3 (pl) Sposób jodowania związków aromatycznych
BRPI0907122A2 (pt) Piridoindóis (1-azinona) substituídos
IL212622A0 (en) Biomarkers for assessing atherosclerotic potential
EP1990627A4 (en) METHOD FOR ANALYZING AN OPTICAL MEASUREMENT
FI20085283A7 (fi) Menetelmä kaasujen mittaamiseksi
AT505325A3 (de) Prüfstand
DK2367562T3 (da) Glycanspecifikke analyseværktøjer
DK2272538T3 (da) Fremgangsmåde til påvisning af blærecancer
FI20095206A0 (fi) Menetelmä mittaukseen höyrystyspinnalta
NO20081652L (no) Anordning ved renseverktoy
FI20075954L (fi) Menetelmä orgaanisen pigmentin valmistamiseksi
DE602006006115D1 (de) Fixierungsvorrichtung für Fahrradnabe
DK2318809T3 (da) Enhed til fjernmåling